[調査レポート]組織処理システム市場は、2019 年の 3 億 3,578 万米ドルから 2027 年までに 4 億 9,376 万米ドルに達すると予想されます。市場は、2020 年から 2027 年にかけて 5.1% の CAGR で成長すると推定されています。
組織処理は、組織の固定と包埋、およびパラフィン ブロックの切片化の間のステップです。この技術は、組織を固体培地に入れて顕微鏡分析用に組織を調製する際に使用されます。組織処理は、スライドガラスに取り付けられ、正常および異常な構造を示すために適切に染色された非常に薄くて高品質のスライスを提供するのに役立ちます。世界の組織処理システム市場の成長は、主にがんの有病率の増加や診断数の増加などの要因に起因しています。研究室。しかし、がん診断の高額なコストが市場の成長を制限しています。
組織処理システムの収益性の高い地域市場
市場洞察
がんの有病率の増加
h3>
組織処理システムは、がん診断研究室で広く使用されています。生検サンプルは、がん診断のために組織処理装置で処理されます。ティッシュ プロセッサーは 1940 年代から広く入手可能であり、使いやすく、取り扱いも簡単です。大量のサンプルを管理し、サンプルを迅速に処理して、高品質の結果を生み出すことができます。
世界保健機関 (WHO) によると、がんは世界中で第 2 位の死因となっています。 2018年には、この病気により世界中で960万人が死亡しました。さらに、世界中でおよそ 6 人に 1 人ががんで死亡しています。欧州におけるがん症例数の増加と欧州における先進的な診断インフラストラクチャは、欧州市場の成長を促進すると考えられます。たとえば、共同研究センターは、2020年7月に欧州連合におけるがん有病率に関する2020年の推計を発表しました。その推計では、がんによる負担は2020年に新たに270万人に増加し、130万人が死亡しました。
したがって、有病率は増加しています。がんの増加により、診断における組織プロセッサの需要が高まります。
製品ベースの洞察
組織処理システム市場は、製品ごとに組織移送プロセッサと流体移送プロセッサに分類されます。 2019年には流体移送プロセッサーセグメントが市場でより大きなシェアを占めましたが、組織移送プロセッサーセグメントは予測期間中に市場でより高いCAGRを記録すると予想されます。組織移送プロセッサにより、試薬の使用に柔軟性が与えられ、ユーザーは試薬に対して異なるスケジュールを実行できるようになります。
組織処理システム市場、製品別 - 2019 年および 2027 年
ボリュームベースの洞察
組織処理システム市場は、ボリューム別に、少量に分類されますプロセッサ、中容量プロセッサ、および大容量プロセッサ。 2019 年は小規模プロセッサ セグメントが市場で最大のシェアを占め、中量プロセッサ セグメントが予測期間中に最高の CAGR を記録すると予想されます。
エンド ユーザー ベースの洞察
< p>エンドユーザーに基づいて、組織処理システム市場は病院、製薬会社、研究所などに分類されます。 2019 年には病院セグメントが市場で最大のシェアを占めましたが、製薬会社セグメントは予測期間中に 5.7% という最高の CAGR を記録すると推定されています。
戦略的洞察
製品上市と承認は、世界的な拠点と製品ポートフォリオを拡大するために企業が一般的に採用する戦略です。コラボレーションは、組織処理システム市場のプレーヤーが世界中の顧客ベースを拡大するために採用する主要な戦略の 1 つであり、これにより企業はブランド名を世界的に維持することもできます。
組織処理システム市場 – 製品別
- 組織移送プロセッサ
- 流体移送プロセッサ
組織処理システム市場 - 容量別
- 小容量プロセッサ
- 中容量プロセッサ
- 大容量プロセッサ
組織処理システム市場 - エンドユーザー別
- 病院
- 製薬会社
- 研究所
- その他
組織処理システム市場 - 地域別
- 北米
- 米国
- カナダ
- メキシコ
- ヨーロッパ
- フランス
- ドイツ
- イタリア
- 英国
- スペイン
- その他のヨーロッパ
- アジア太平洋 (APAC)
- 中国
- インド
- 韓国
- 日本
- オーストラリア
- アジア太平洋地域のその他の地域
- 中東およびアフリカ (MEA)
- 南アフリカ
< li>サウジアラビア - アラブ首長国連邦
- MEAの残りの地域
- ブラジル
- アルゼンチン
- 中南米のその他の地域
会社概要
- MiltenyiBiotec
- BioGenex
- Leica Biosystems Nussloch GmbH (ダナハー)
- Avantor, Inc.
- THERMO FISHER SCIENTIFIC INC.
- シーメンス AG
- F.ホフマン・ラ・ロシュ株式会社
- アジレント テクノロジー株式会社
- マイルストーン メディカル
- サクラ ファインテック USA, Inc.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Tissue processing occurs between tissue fixation and the embedding as well as the sectioning of the paraffin blocks. Tissue processing is used in the preparation of the tissue for microscopic analysis by putting the tissue in a solid medium. Tissue processing helps to provide very thin and high-quality slices mounted on the glass slides and properly stained to indicate normal and abnormal structures.
The factors that are driving growth of the market are increasing prevalence of cancer and rising number of diagnostic laboratories are factors driving the market growth. However, high cost of cancer diagnosis may hinder the market growth.
The tissue processing systems market majorly consists of the players such as Agilent Technologies, Inc., Biogenex Laboratories, Sakura Finetek Usa, Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Siemens Ag, Avantor, Milestone Medical, Leica Biosystems (Danaher Corporation), Miltenyi Biotec amongst others.
The List of Companies - Tissue Processing Systems Market
- Agilent Technologies Inc.
- Biogenex Laboratories
- Sakura Finetek Usa Inc.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche AG
- Siemens Ag
- Avantor
- Milestone Medical
- Leica Biosystems (Danaher Corporation)
- Miltenyi Biotec
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Dec 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Dec 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Dec 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Dec 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)